Takata Airbag

The Takata airbag docket, built on claims that defective ammonium-nitrate-based inflators could rupture and expel metal fragments during deployment, now carries 78 pending actions after a decade of litigation that included Takata's corporate bankruptcy and a series of automaker-specific economic-loss settlements alongside the personal-injury and wrongful-death track. That history matters for funding purposes: the underlying defect mechanism, automaker knowledge, and recall scope have all been extensively documented across parallel regulatory, criminal, and civil proceedings, giving any remaining personal-injury or wrongful-death claim a well-developed evidentiary foundation rather than a novel causation theory.

Funding availability for a claim still active in this docket should account for the corporate-bankruptcy backdrop — Takata's own bankruptcy reorganized how certain claims against the manufacturer are administered, meaning recovery paths and timing can differ depending on whether a claim proceeds primarily against Takata's successor entity, against an automaker as a co-defendant, or through a claims-administration mechanism tied to the bankruptcy. Diligence on any remaining claim needs to identify which of those paths applies before sizing an advance.

Medical-lien considerations are significant for personal-injury claims here given the nature of the alleged harm — shrapnel injuries from inflator rupture can involve severe facial, neck, or eye trauma requiring extensive surgical treatment — and wrongful-death claims carry their own estate and dependency-damages considerations rather than lien exposure.

Given the claim-specific complexity introduced by the bankruptcy history and the relatively modest remaining pending-action count, individual claim evaluation is generally more appropriate than broad portfolio-scale inventory finance in this docket. Criterica Capital's mass-tort finance and medical-lien receivables products apply depending on the specific claim's posture.

Criterica Intelligence's structural brief covers how the corporate-bankruptcy and multi-automaker-defendant structure shapes resolution paths in this docket.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.